Saint-Germain-en-Laye, France – Takara Bio announces the launch of PrimeCap™ T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development. PrimeCap T7 RNA Polymerase is a mutant T7 RNA polymerase that has been genetically engineered to maintain high-performance RNA synthesis activity while reducing dsRNA production to less than […]

The SOPHiA DDM™ Platform will help broaden the hospital’s cancer testing and diagnostic capabilities  Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDM™ Platform. The hospital will use […]

Strategic partnership enables companies to combine technology offerings and streamline NGS workflows CORALVILLE, Iowa and HEIDELBERG, Germany  — Genomics solutions provider Integrated DNA Technologies (IDT) and Bio-IT company Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their next generation sequencing (NGS) capabilities. The partnership pairs IDT’s Archer NGS […]

Consortium Selects Leading Genomics Companies to Support Pediatric Mendelian Genomics Research Center Program ALISO VIEJO, Calif. and MENLO PARK, Calif. — Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced their companies’ […]

The Applied Biosystems™ Axiom™ BloodGenomiX™ Array and Software provide a high-throughput solution for more precise blood matching research WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Applied Biosystems™ Axiom™ BloodGenomiX™ Array* and Software, a first-of-its-kind solution for more precise blood genotyping in clinical research. The new array detects […]

As the first NGS interpretation platform for both oncology and hereditary applications, the updated version of QIAGEN Clinical Insight Interpret is approved for diagnostic use Regulatory framework ensures greater patient protection, transparency of information, and traceability of data Over 4 million NGS patient test cases for oncology and hereditary diseases worldwide processed with QIAGEN Clinical […]

Donation will assist in the development of antisense oligonucleotide (ASO) medicines to nano-rare disease patients worldwide Third consecutive annual donation, now totaling around $1.4 million Cytiva has donated approximately $700,000 worth of products and financial support to the n-Lorem Foundation. This is Cytiva’s third year of providing support to the foundation whose mission is to […]

SAN DIEGO — Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced record growth in installations of its AVITI™ System ahead of its participation in upcoming investor conferences. Element has now received more than 200 cumulative orders of AVITI – the sequencer that provides the highest quality sequencing on a benchtop for […]

Collaboration expands Aldevron’s capabilities in mRNA lipid nanoparticle encapsulation FARGO, N.D. and VANCOUVER, B.C. — Aldevron, a leading global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, today announced it has entered a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company specializing in the development of delivery […]

GenScript continues to build on its fast and dependable in vitro transcription RNA synthesis service, offering a new self-amplifying RNA format that enhances the potency and efficacy of vaccines, immunotherapies, and gene therapies PISCATAWAY, N.J. — GenScript Biotech Corporation, a global leader in life science research tools and services, has today announced the expansion of its in vitro transcription […]